在瘤进展中的C-反应性蛋白信号通路
Eun-Sook Kim1, Sun Young Kim2, Aree Moon1
1Duksung Innovative Drug Center, College of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea.
Biomolecules & therapeutics
|August 10, 2023
概括
在炎症性瘤微环境中,C-反应蛋白 (CRP) 通过促进瘤生长,转移和血管生成来推动癌症的进展. 了解CRP信号是解开炎症与癌症联系的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 慢性炎症创造了一个瘤微环境,促进癌症的进展,转移和血管生成.
- 在这种微环境中细胞分泌的炎症因素可以诱导癌细胞的增殖和存活.
- 识别特定的炎症因素,如C反应蛋白 (CRP) 的作用,对于理解癌症的发展至关重要.
研究的目的:
- 审查C反应蛋白 (CRP) 在各种癌症类型中的信号通路和作用.
- 探索CRP,炎症和瘤微环境之间的关联.
- 突出CRP在乳腺,肝脏,脏和胰腺癌的特定参与.
主要方法:
- 在癌症中研究C反应蛋白 (CRP) 的研究文献综述.
- 分析CRP在瘤微环境中的信号通路中的作用.
- 检查CRP对癌细胞增殖,存活,转移和血管生成的影响.
主要成果:
- CRP与乳腺癌的进展有关,特别是三阴性乳腺癌 (TNBC),增强侵袭性和瘤形成.
- CRP促进血管生成,并在胰腺和脏癌症中促进瘤的进展.
- 在肝癌中,CRP影响炎症反应和脂质代谢,并调节瘤微环境中的免疫细胞.
结论:
- 通过不同的机制,C-反应蛋白 (CRP) 在促进各种癌症类型的癌症进展方面发挥着重要作用.
- CRP信号通路与其他炎症媒介相互作用,有助于炎症和癌症之间的复杂关系.
- 对CRP相互作用的进一步研究对于开发向癌症疗法和理解炎症驱动的瘤发生至关重要.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
01:20The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
01:22PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
01:07MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K